![Passage Bio Inc](/common/images/company/N_PASG.png)
Passage Bio Inc (PASG)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -39.81M | -27.53M | -28.24M | -35.88M | -25.39M | -23.28M | -18.45M | -18.05M |
Pre Tax Income | -39.54M | -26.7M | -27.07M | -34.34M | -23.86M | -27.11M | -16.76M | -16.71M |
Net Income | -39.54M | -26.7M | -27.07M | -34.34M | -23.86M | -27.11M | -16.76M | -16.71M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -39.81M | -27.53M | -28.24M | -34.34M | -23.86M | -21.72M | -22.36M | -16.71M |
EBITDA | -38.89M | -26.6M | -27.3M | -34.91M | -24.41M | -22.32M | -17.64M | -17.24M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -13.47M | -37.19M | -112.9M | -185.73M | -138.39M | -103M |
Pre Tax Income | -12.77M | -45.63M | -112.23M | -185.39M | -136.13M | -102.06M |
Net Income | -12.77M | -45.63M | -112.23M | -185.39M | -136.13M | -102.06M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.687 | -2.398 | -2.46 | -3.418 | -2.492 | -1.862 |
EBIT | -12.77M | -46.33M | -112.9M | -185.73M | -138.39M | -102.27M |
EBITDA | -13.47M | -37.06M | -112.1M | -184.19M | -134.72M | -99.28M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.